Longitude Capital Partners II, LLC, 10% Owner at Aimmune Therapeutics, Inc. (AIMT), bought 3,561,100 shares at $16.00 ($5.0M) on 2015-08-11, disclosed to the SEC on 2015-08-11.
Open-market purchase of $5.0M AIMT by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 3,248,600 | $0 | 0.0% |
| 2 | $16.00 | 312,500 | $5.0M | 100.0% |
| Total | $1.40 avg | 3,561,100 | $5.0M | 100% |
| Filing → |